Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-8,000
Closed -$249K 1050
2016
Q1
$249K Sell
8,000
-28,800
-78% -$880K 0.01% 694
2015
Q4
$1.23M Sell
36,800
-15,700
-30% -$584K 0.03% 393
2015
Q3
$1.98M Buy
52,500
+14,700
+39% +$601K 0.05% 306
2015
Q2
$1.82M Sell
37,800
-7,100
-16% -$365K 0.05% 343
2015
Q1
$2.25M Sell
44,900
-28,100
-38% -$1.52M 0.05% 266
2014
Q4
$4.78M Buy
73,000
+50,100
+219% +$3.49M 0.08% 202
2014
Q3
$1.74M Sell
22,900
-12,900
-36% -$1.07M 0.03% 518
2014
Q2
$2.95M Sell
35,800
-32,293
-47% -$2.41M 0.05% 301
2014
Q1
$4.78M Buy
68,093
+42,919
+170% +$2.94M 0.09% 189
2013
Q4
$1.8M Buy
+25,174
New +$1.83M 0.02% 539

Other funds holding NOV

Integral Derivatives's NOV Position: Q2 2015 in Review

Integral Derivatives sold out of NOV (NOV) in Q2 2015, closing a stake of 13,816 shares — an estimated $710K sold.

Integral Derivatives first reported a position in NOV in Q1 2014 and held it in 4 quarters. The position peaked at $4.11M in Q3 2014. 783 funds tracked by Wall St. Rank hold NOV as of Q2 2015.

  • Integral Derivatives reported no remaining NOV position as of Q2 2015 after selling out during the quarter.
  • Integral Derivatives sold 13,816 NOV shares in Q2 2015, an estimated $710K.
  • Integral Derivatives first reported a position in NOV in Q1 2014 and held it in 4 quarters.
  • Integral Derivatives's NOV position peaked at $4.11M in Q3 2014.
  • 783 funds tracked by Wall St. Rank held NOV as of Q2 2015.

Based on Integral Derivatives's 13F filing for Q2 2015, filed 15 Jul 2015.